Form 4: Zivo Bioscience Director Alison Cornell Acquires Shares and Warrants

Director Alison Cornell purchased 11,990 shares of Zivo Bioscience and related warrants at $8.34 per share on August 22, 2024.

Summary

• On August 22, 2024, Alison Cornell, a director of Zivo Bioscience, Inc., acquired 11,990 shares of common stock at a price of $8.34 per share.
• The same transaction also involved the acquisition of 1,199 common stock purchase warrants, also at a price of $8.34.
• Following the reported transaction, Cornell directly owns 257,975 shares of Zivo Bioscience common stock.
• Cornell also directly owns 1,199 common stock purchase warrants, which are exercisable until August 22, 2029.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. A director purchasing shares is generally a good sign, but it's a relatively small transaction.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

This is a standard SEC Form 4 filing, which is required when a company insider (such as a director or officer) buys or sells shares of their company's stock. It provides transparency into insider transactions.

Stakeholder Impact

• The purchase could have a slightly positive impact on shareholder sentiment.

Key Dates

Keywords

Zivo Bioscience, Director, Insider Trading, Form 4, Stock Purchase, Warrants, Ownership